← Eichor
Study identifier: NCT07534345 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse

Condition: Provoked Vestibulodynia  ·  Sponsor: Université de Sherbrooke

PhaseNA
Planned participants170
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

Chronic vulvar pain is a highly prevalent and debilitating condition affecting up to 16% of women. The most common subtype of vulvar pain, provoked vestibulodynia (PVD), is characterized by a sharp pain at the entry of the vagina in response to pressure or attempted vaginal penetration. Women with PVD not only present with psychological distress and significant disruption in all aspects of sexual function, but they are also confronted with limited effective treatment options. Dry needling (DN) could fill this therapeutic gap. Similar to acupuncture, this approach involves the insertion of fine needles into the tissues. However, its mechanisms of action are quite different. DN specifically targets muscle tension/stiffness, which has been shown to play a key role in PVD. After designing a DN treatment protocol tailored to the affected muscles in PVD, our randomized pilot study confirmed that our state-of-the-art DN treatment protocol is feasible and acceptable for treating PVD and the promising findings obtained provide support for conducting the proposed large-scale study. The proposed multicenter randomized controlled trial aims to establish the efficacy of DN for reducing pain in women with PVD. Women will be randomized to receive either sham or real DN for 8 weekly sessions. Validated outcome measures will be assessed at baseline, post-treatment and at the 6-month follow-up. The current proposal addresses the urgent need to develop novel treatment options for women with P…

This description comes directly from the study's public registry record.

Talk to the study team

Camille Simard, MSc  ·  1-888-463-1835  ·  labomorin@usherbrooke.ca

Kathryne Brûlé, MSc  ·  1-819-821-8000  ·  labomorin@usherbrooke.ca

Always discuss trial participation with your own doctor first.

Locations (4)

Centre hospitalier universitaire de Québec - Université LavalQuébec, Quebec, CanadaNot Yet Recruiting
Kinatex l'OrmièreQuébec, Quebec, CanadaNot Yet Recruiting
Centre hospitalier universitaire de SherbrookeSherbrooke, Quebec, CanadaRecruiting
CigoniaSherbrooke, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07534345